Health
Breakthroughs and beating the odds.
Shigella vaccine candidate shows 89% efficacy in trial
The WRSs2 vaccine achieved 89% efficacy in a phase 2 trial against Shigella sonnei, the highest for any candidate.
FDA Approves First Oral Therapy for Covid-19 Prevention
The FDA has approved Shionogi’s Xocova as the first oral therapy for Covid-19 post-exposure prophylaxis in adolescents and adults.
Moderna and Merck report mRNA vaccine reduces melanoma risk
A trial shows an mRNA vaccine significantly lowers melanoma recurrence risk in high-risk patients.
UCLA trial shows cancer vaccine elicits strong immune response
A novel cancer vaccine targeting KRAS mutations shows strong immune responses in patients with pancreatic and colorectal cancer.
FDA Approves Monthly Injection for Ulcerative Colitis Treatment
The FDA has approved a new once-monthly injection regimen for Eli Lilly’s Omvoh to treat ulcerative colitis.
Cambridge's pEVAC-PS Vaccine Trial Shows Positive Results
The University of Cambridge has completed a phase 1 trial of an AI-designed vaccine, pEVAC-PS, targeting sarbecoviruses.
FDA Approves First Gene Therapy for Wiskott-Aldrich Syndrome
Waskyra, the first gene therapy for Wiskott-Aldrich syndrome, shows significant reduction in severe infections and bleeding events.
UCLA KRAS Vaccine Shows Promising Results in Cancer Trial
A novel cancer vaccine, ELI-002 2P, demonstrated strong immune responses in 25 patients with KRAS-driven cancers.
WRSs2 Shigella Vaccine Shows 89% Efficacy in Phase 2 Trial
A Phase 2 trial found the WRSs2 vaccine provided 89% protection against Shigella sonnei infection.
FDA Approves Kresladi Gene Therapy for Immune Disorder
The FDA has approved Kresladi, a gene therapy for severe leukocyte adhesion deficiency-I, providing new hope for patients.
FDA approves new viral immunotherapy for advanced melanoma
The FDA has granted accelerated approval for Tudriqev, a new oncolytic viral therapy for advanced melanoma, on August 29, 2026.
CAR T-cell therapy shows promise for severe rheumatoid arthritis
CAR T-cell therapy has led to significant improvements in patients with severe rheumatoid arthritis, with some achieving remission.
AI-Designed Coronavirus Vaccine Passes First Human Trial
A novel AI-designed universal coronavirus vaccine has successfully completed its first human trial, demonstrating safety and efficacy.
Rotavirus vaccine decreases gastroenteritis deaths by 75.8%
A global study reveals the rotavirus vaccine cuts deaths from gastroenteritis by 75.8% among vaccinated children.
GSK drug bepirovirsen shows functional cure for hepatitis B in trials
GSK’s bepirovirsen achieved functional cures in 19-20% of hepatitis B patients in two Phase 3 trials.
Gene Therapy Restores Immune Function in 95% of ADA-SCID Children
A gene therapy for ADA-SCID has restored immune function in 59 of 62 treated children, achieving a 95% success rate.
Phase 2 Trial Shows 89% Efficacy for Shigella Vaccine
A phase 2 trial for the WRSs2 vaccine against Shigella sonnei achieved 89% efficacy with no serious adverse events.
Moderna and Merck's mRNA cancer vaccine shows promise in Phase 3 trial
A Phase 3 trial indicates that the mRNA vaccine intismeran autogene reduces melanoma recurrence risk.
GSK's Bepirovirsen Shows Promise as Functional Cure for Hepatitis B
GSK's bepirovirsen achieved functional cures in 19% of participants in phase 3 trials for hepatitis B.
EPA updates testing methods to reduce animal use in chemical safety reviews
The U.S. EPA announces advancements to modernize chemical safety assessments while minimizing animal testing.
Wolbachia mosquito release reduces dengue infections in Singapore
A trial in Singapore showed that releasing Wolbachia-infected mosquitoes cut dengue infections by 71-72% among residents.
FDA Approves Kresladi, First Gene Therapy for Severe LAD-I
The FDA has approved Kresladi, the first gene therapy for severe leukocyte adhesion deficiency-I, restoring immune function in children.
Stem Cell Scaffold Enhances Vision in First Human Trial for ARK
A dual stem cell scaffold improved vision in a first-in-human trial for aniridia-related keratopathy at Moorfields Eye Hospital.
Gene Therapy Restores Immune Function in Children with ADA-SCID
An experimental gene therapy has successfully restored immune function in 59 of 62 children with ADA-SCID.
Moderna and Merck Report Success in Melanoma Vaccine Trial
Merck and Moderna announced that their Phase 3 trial of the mRNA cancer vaccine intismeran met its primary and key secondary endpoints for patients with melanoma.
Moderna's mRNA Influenza Vaccine Approved by FDA
The FDA has approved mFlusiva, the first mRNA-based flu vaccine, showing greater effectiveness in preventing influenza.
Moderna and Merck's mRNA Melanoma Vaccine Shows Positive Trial Results
Merck and Moderna report significant trial success for an mRNA-based melanoma therapy combined with KEYTRUDA.
New low-cost treatment restores sight for thousands in rural clinics
A simple, affordable procedure is reaching communities that previously had no access to eye care.
Charity funds life-saving heart surgery for 500th child this year
Families who could never afford care are watching their children run and play for the first time.
New malaria vaccine rollout cuts child cases by 75% in trial regions
Health workers call it the biggest leap against the disease in a generation.